Journal article
New uses for old drugs: neonatal diabetes and sulphonylureas.
- Abstract:
- The discovery that their neonatal diabetes is caused by gain-of-function mutations in the K(ATP) channel has enabled many patients to switch from insulin to oral sulphonylurea drugs. Here, I review molecular, physiological, and clinical features of this change in therapy.
- Publication status:
- Published
Actions
Authors
- Journal:
- Cell metabolism More from this journal
- Volume:
- 11
- Issue:
- 3
- Pages:
- 179-181
- Publication date:
- 2010-03-01
- DOI:
- EISSN:
-
1932-7420
- ISSN:
-
1550-4131
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:113351
- UUID:
-
uuid:c032ee06-3b9a-4fa7-a693-f206a719f84b
- Local pid:
-
pubs:113351
- Source identifiers:
-
113351
- Deposit date:
-
2012-12-19
Terms of use
- Copyright date:
- 2010
If you are the owner of this record, you can report an update to it here: Report update to this record